Zogenix Provides Update on FDA Advisory Committee Meeting for Zohydro(TM) ER for Management of Chronic Pain
[at noodls] – Zogenix to Host Conference Call on Dec. 7, 2012 at 6:30 p.m. ET SAN DIEGO, Dec. 7, 2012 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products … more
View todays social media effects on ZGNX
View the latest stocks trending across Twitter. Click to view dashboard